We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Source Bio. | LSE:SBS | London | Ordinary Share | GB0009739649 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.50 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSBS
RNS Number : 9231J
Source BioScience PLC
15 September 2016
AMMENT
Please be advised that this announcement replaces the version previously released on 14 August 2016 under RNS number 8695J. The number of share options held has been amended to 'nil'. All other information remains unchanged.
FORM 8 (DD)
PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)
Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Full name of discloser: Mr Tim Metcalfe (Finance Director of Source BioScience plc) ----------------------------------- ---------------------- (b) Owner or controller N/A of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. ----------------------------------- ---------------------- (c) Name of offeror/offeree Source BioScience in relation to whose relevant plc securities this form relates: Use a separate form for each offeror/offeree ----------------------------------- ---------------------- (d) Status of person making Person acting the disclosure: in concert with e.g. offeror, offeree, the offeree person acting in concert with the offeror/offeree (specify name of offeror/offeree) ----------------------------------- ---------------------- (e) Date dealing undertaken: 13 September 2016 ----------------------------------- ---------------------- (f) In addition to the N/A company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" ----------------------------------- ---------------------- 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing
Class of relevant security: --------------------------- ------------------------------------- Interests Short positions --------------------------- ----------------- ------------------ Number % Number % --------------------------- ---------- ----- ------------- --- (1) Relevant securities owned and/or controlled: 1,606,154 0.4% nil - --------------------------- ---------- ----- ------------- --- (2) Cash-settled nil - nil - derivatives: --------------------------- ---------- ----- ------------- --- (3) Stock-settled nil - nil - derivatives (including options) and agreements to purchase/sell: --------------------------- ---------- ----- ------------- --- TOTAL: 1,606,154 0.4% nil - --------------------------- ---------- ----- ------------- ---
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Nil.
3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)
Class of Purchase/sale Number of Price per relevant securities unit security ---------- -------------- ------------ ---------- n/a n/a n/a n/a ---------- -------------- ------------ ----------
(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser
Class Purchases/ Total Highest Lowest of relevant sales number price price security of securities per unit per unit paid/received paid/received ------------- ----------- --------------- --------------- --------------- n/a n/a n/a n/a n/a ------------- ----------- --------------- --------------- --------------- (b) Cash-settled derivative transactions Class Product Nature of Number Price of relevant description dealing of reference per unit security e.g. e.g. opening/closing securities CFD a long/short position, increasing/reducing a long/short position ------------- ------------- ---------------------- -------------- ---------- n/a n/a n/a n/a n/a ------------- ------------- ---------------------- -------------- ---------- (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class Product Writing, Number Exercise Type Expiry Option of descriptione.g. purchasing, of price e.g. date money relevant call selling, securities per American, paid/ security option varying to unit European received etc. which etc. per option unit relates ---------- ----------------- ------------- ------------ --------- ----------- ------- ---------- n/a n/a n/a n/a n/a n/a n/a n/a ---------- ----------------- ------------- ------------ --------- ----------- ------- ---------- (ii) Exercise Class Product Exercising/ Number Exercise of relevant description exercised of securities price security e.g. call against per unit option ------------- ------------- ------------ --------------- ---------- Ordinary Share Exercised 1,606,154 Nil shares options of 2 pence each ------------- ------------- ------------ --------------- ---------- (d) Other dealings (including subscribing for new securities) Class of Nature of dealing Details Price relevant e.g. subscription, per unit security conversion (if applicable) ---------- -------------------- -------- ----------------- n/a n/a n/a n/a ---------- -------------------- -------- ----------------- 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" ------------------------------------------------ None ------------------------------------------------ (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" -------------------------------------------------- None -------------------------------------------------- (c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO ------------------------------------- --- Supplemental Form 8 (SBL) NO ------------------------------------- --- Date of disclosure: 14 September 2016 --------------------- --------------------- Contact name: Nick Ash (Company Secretary) --------------------- --------------------- Telephone number: +44 (0) 115 973 9010 --------------------- ---------------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DCCLIFLDAAIELIR
(END) Dow Jones Newswires
September 15, 2016 03:30 ET (07:30 GMT)
1 Year Source Bioscience Chart |
1 Month Source Bioscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions